AUSTIN, Texas, August 25, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 27th Annual Global Investment Conference, which is being held September 8-10, 2025, in New York City. Date: Tuesday, September 9th Time: 8:30-9:00 AM ET Location: Lotte New York Palace Hotel Webcast: https://journey.ct.ev ...

FDA PDUFA goal date extended by three monthsALACHUA, Fla. and TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Biologics License Application (BLA) for Avance® Nerve Graft by three months to December 5, 2025. On August 22, 2025, the Company received a communication from the FDA indicating that the information submitted by the Company in response ...

Pressure is mounting on the medical device maker.One of famed investor Warren Buffett's principles is to buy shares of wonderful companies at fair prices to hold for the long term. Let's try to use it to decide whether Intuitive Surgical (ISRG 1.22%), a medical device specialist, is worth investing in today.The healthcare giant certainly appears to be a wonderful company. Intuitive Surgical is helping revolutionize medicine through innovations in robotic surgery. The company's da Vinci system, the first rob ...

If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000).Dividend investing can be tricky, since income-focused investors want to find high yields while also avoiding stocks that end up cutting their quarterly payouts. There's a balance that has to be found, and company quality is highly important to consider. That's why you should be interested in dividend-paying healthcare stocks like Johnson & Johnson (JNJ 0.08%), Medtronic (MDT 1.66%), and Omega ...

Terumo has agreed to buy UK-based organ medical tech company OrganOx in a deal valued at around $1.5 billion, seeking entry into the organ transplant field https://t.co/2bgUEll9sE ...

Amazon's flywheel is still accelerating Why Intuitive Surgical's runway keeps getting longer Intuitive posted a strong Q2, with revenue up 21% year over year to $2.44 billion and non‑GAAP diluted earnings per share (EPS) of $2.19 -- up 23%. Growth was broad-based across its different key sales drivers -- instruments, accessories, and systems placements. This momentum reflects rising procedure volume and continued adoption of the company's latest minimally invasive surgical platform: the da Vinci 5. The life ...

Core Viewpoint - The article emphasizes the resilience of certain healthcare companies, specifically Medtronic and Johnson & Johnson, in maintaining and increasing their dividends despite facing various challenges in the market. Group 1: Medtronic - Medtronic is a leading medical device company that has faced challenges, including tariffs impacting financial results, yet it has performed well this year and exceeded analyst estimates [4] - The company has a strong underlying business with consistent revenue and earnings growth, driven by the development and marketing of new products across multiple therapeutic areas [6] - Medtronic has increased its dividends for 48 consecutive years, with a current forward yield of 3.1%, significantly higher than the S&P 500's average of 1.3% [8] Group 2: Johnson & Johnson - Johnson & Johnson is also encountering challenges, such as tariff-related issues and generic competition, but it has shown strong performance and increased its guidance for fiscal year 2025 [9] - The pharmaceutical segment is well-diversified, with robust R&D spending leading to consistent new product launches, helping to offset losses from products that have fallen out of patent protection [10] - Johnson & Johnson has a long history of dividend increases, with 62 consecutive years, and maintains a higher credit rating than the U.S. government, indicating its capability to fulfill financial obligations despite recent challenges [12][13]

Group 1 - Halper Sadeh LLC is investigating ZimVie Inc. for potential violations of federal securities laws related to its sale to an affiliate of ARCHIMED for $19.00 per share in cash [1] - City Office REIT, Inc. is under investigation for its sale to MCME Carell Holdings for $7.00 per share in cash [2] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4] - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Align Technology, Inc. for possible violations of federal securities laws and unlawful business practices [1][2]. Financial Performance - Align Technology announced its Q2 2025 financial results on July 30, 2025, missing both analyst expectations and its own revenue guidance [2]. - The company subsequently lowered its Q3 revenue guidance and full-year growth expectations, leading to a nearly 37% drop in its share price the following day [2]. Legal Actions - The law firm is encouraging investors who suffered losses from Align's stock to contact them to discuss their legal rights and options [1][3]. - The investigation focuses on whether Align issued false or misleading statements or failed to disclose important information to investors [2]. Firm Background - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation across the United States [4].

Group 1 - The article discusses the investment outlook for Inspire Medical Systems (NYSE: INSP), particularly in the sleep apnea sector, highlighting a previous positive sentiment that was disrupted by recent delays announced by the company [1] - The investment group "Value In Corporate Events" focuses on providing actionable ideas related to major corporate events such as IPOs, mergers & acquisitions, and earnings reports, aiming to identify the best investment opportunities [1] - The coverage includes approximately 10 major events each month, indicating a systematic approach to capitalizing on significant market movements [1]